HR 2450 · Prescription Drug Transparency and Affordability Act
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Introduced
- Mar 27, 2025
- Latest action
- Mar 27, 2025
- Sponsor
- Rep. Kristen McDonald Rivet [D-MI-8]
- Policy area
- Health
- Cosponsors
- 3
Recent actions
- Mar 27, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 27, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 27, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Mar 27, 2025 Introduced in House
- Mar 27, 2025 Introduced in House
Votes
No recorded votes are available for this bill.